85 related articles for article (PubMed ID: 16185477)
1. [Specific targeting cytotoxicity to resistant leukemia cells mediated by anti-Pgp/anti-CD3 diabody].
Gao YD; Xiong DS; Yang M; Xu YF; Shao XF; Peng H; Fan DM; Yang CZ
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):342-4. PubMed ID: 16185477
[TBL] [Abstract][Full Text] [Related]
2. Efficient inhibition of multidrug-resistant human tumors with a recombinant bispecific anti-P-glycoprotein x anti-CD3 diabody.
Gao Y; Xiong D; Yang M; Liu H; Peng H; Shao X; Xu Y; Xu C; Fan D; Qin L; Yang C; Zhu Z
Leukemia; 2004 Mar; 18(3):513-20. PubMed ID: 14981526
[TBL] [Abstract][Full Text] [Related]
3. [Study of specific targeting cytotoxicity mediated by anti-CD(3)/anti-CD(20) Diabody].
Xiong D; Shao X; Yang C; Xu Y; Liu H; Han J; Peng H; Yang M; Zhu Z
Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):359-62. PubMed ID: 11877098
[TBL] [Abstract][Full Text] [Related]
4. Extracellular domain of 4-1BBL enhanced the antitumoral efficacy of peripheral blood lymphocytes mediated by anti-CD3 x anti-Pgp bispecific diabody against human multidrug-resistant leukemia.
Guo H; Jiang W; Liu W; Gao Y; Yang M; Zhou Y; Wang J; Qi J; Cheng X; Zhu Z; Yang C; Xiong D
Cell Immunol; 2008 Feb; 251(2):102-8. PubMed ID: 18482719
[TBL] [Abstract][Full Text] [Related]
5. [Construction and expression of anti-CD3/ anti-Pgp Diabody].
Gao YD; Xiong DS; Xu YF; Peng H; Shao XF; Yang CZ; Zhu ZP
Sheng Wu Gong Cheng Xue Bao; 2003 Jul; 19(4):444-9. PubMed ID: 15969062
[TBL] [Abstract][Full Text] [Related]
6. [An anti-P-gp/anti-CD3 bispecific antibody cytotoxic to human multidrug resistant KB cells].
Gao YD; Xiong DS; Yang M; Xu YF; Shao XF; Peng H; Fan DM; Yang CZ
Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):653-6. PubMed ID: 16438884
[TBL] [Abstract][Full Text] [Related]
7. A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells.
Bühler P; Wolf P; Gierschner D; Schaber I; Katzenwadel A; Schultze-Seemann W; Wetterauer U; Tacke M; Swamy M; Schamel WW; Elsässer-Beile U
Cancer Immunol Immunother; 2008 Jan; 57(1):43-52. PubMed ID: 17579857
[TBL] [Abstract][Full Text] [Related]
8. Improvement of tumor targeting and antitumor activity by a disulphide bond stabilized diabody expressed in Escherichia coli.
Liu J; Yang M; Wang J; Xu Y; Wang Y; Shao X; Yang C; Gao Y; Xiong D
Cancer Immunol Immunother; 2009 Nov; 58(11):1761-9. PubMed ID: 19259665
[TBL] [Abstract][Full Text] [Related]
9. A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.
Reusch U; Duell J; Ellwanger K; Herbrecht C; Knackmuss SH; Fucek I; Eser M; McAleese F; Molkenthin V; Gall FL; Topp M; Little M; Zhukovsky EA
MAbs; 2015; 7(3):584-604. PubMed ID: 25875246
[TBL] [Abstract][Full Text] [Related]
10. Redirection of CD4+ and CD8+ T lymphocytes via an anti-CD3 × anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells.
Fan D; Li W; Yang Y; Zhang X; Zhang Q; Yan Y; Yang M; Wang J; Xiong D
J Hematol Oncol; 2015 Oct; 8():108. PubMed ID: 26444983
[TBL] [Abstract][Full Text] [Related]
11. Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabody.
Fortmüller K; Alt K; Gierschner D; Wolf P; Baum V; Freudenberg N; Wetterauer U; Elsässer-Beile U; Bühler P
Prostate; 2011 May; 71(6):588-96. PubMed ID: 20945402
[TBL] [Abstract][Full Text] [Related]
12. A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cells.
Hayashi H; Asano R; Tsumoto K; Katayose Y; Suzuki M; Unno M; Kodama H; Takemura S; Yoshida H; Makabe K; Imai K; Matsuno S; Kumagai I; Kudo T
Cancer Immunol Immunother; 2004 Jun; 53(6):497-509. PubMed ID: 14648071
[TBL] [Abstract][Full Text] [Related]
13. [Preparation and activity detection of monoclonal antibody against anti-CD3 ScFv].
Shao XF; Gao YD; Liu JN; Wang JH; Xu YF; Fan DM; Yang CZ; Xiong DS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Jun; 30(3):354-9. PubMed ID: 18686622
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activities of PSMA×CD3 diabodies by redirected T-cell lysis of prostate cancer cells.
Baum V; Bühler P; Gierschner D; Herchenbach D; Fiala GJ; Schamel WW; Wolf P; Elsässer-Beile U
Immunotherapy; 2013 Jan; 5(1):27-38. PubMed ID: 23256796
[TBL] [Abstract][Full Text] [Related]
15. [Construction and expression of diabody [CD3 x Pgp] without Etag].
Liu JN; Gao YD; Wang JH; Shao XF; Fan DM; Ji Q; Xiong DS; Yang CZ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Oct; 23(10):946-9. PubMed ID: 17908506
[TBL] [Abstract][Full Text] [Related]
16. [The influence of Ara-C on anti-CD3/anti-Pgp mediating T-lymphocytes activities against multi-drug resistant leukemia cells.].
Yang M; Fan DM; Gao YD; Zhou Y; Ji Q; Shao XF; Wang JH; Xu YF; Xiong DS; Yang CZ
Zhonghua Xue Ye Xue Za Zhi; 2009 Dec; 30(12):812-5. PubMed ID: 20193601
[TBL] [Abstract][Full Text] [Related]
17. Humanization of the bispecific epidermal growth factor receptor x CD3 diabody and its efficacy as a potential clinical reagent.
Asano R; Sone Y; Makabe K; Tsumoto K; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
Clin Cancer Res; 2006 Jul; 12(13):4036-42. PubMed ID: 16818703
[TBL] [Abstract][Full Text] [Related]
18. Efficient inhibition of human B-cell lymphoma in SCID mice by synergistic antitumor effect of human 4-1BB ligand/anti-CD20 fusion proteins and anti-CD3/anti-CD20 diabodies.
Liu R; Jiang W; Yang M; Guo H; Zhang Y; Wang J; Zhu H; Shi R; Fan D; Yang C; Zhu Z; Xie Y; Xiong D
J Immunother; 2010 Jun; 33(5):500-9. PubMed ID: 20463597
[TBL] [Abstract][Full Text] [Related]
19. Efficient inhibition of human B-cell lymphoma xenografts with an anti-CD20 x anti-CD3 bispecific diabody.
Xiong D; Xu Y; Liu H; Peng H; Shao X; Lai Z; Fan D; Yang M; Han J; Xie Y; Yang C; Zhu Z
Cancer Lett; 2002 Mar; 177(1):29-39. PubMed ID: 11809528
[TBL] [Abstract][Full Text] [Related]
20. [Construction and expression of disulphide stabilized anti-CD3/anti-Pgp diabody].
Su Y; Liu J; Gao Y; Qin L; Yang M; Wang J; Xu Y; Shao X; Ji Q; Xiong D; Yang C
Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):1042-8. PubMed ID: 19835146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
